ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: TH-PO551

Single-Cell Spatial Atlas of Immune and Kidney Cell States in Human Rapidly Progressive Glomerulonephritis

Session Information

Category: Glomerular Diseases

  • 1401 Glomerular Diseases: Mechanisms, including Podocyte Biology

Authors

  • Sultana, Zeba, Universitatsklinikum Hamburg-Eppendorf, Hamburg, Hamburg, Germany
  • Khatri, Robin, Universitatsklinikum Hamburg-Eppendorf, Hamburg, Hamburg, Germany
  • Yousefi, Behnam, Universitatsklinikum Hamburg-Eppendorf, Hamburg, Hamburg, Germany
  • Shaikh, Nikhat, Universitatsklinikum Hamburg-Eppendorf, Hamburg, Hamburg, Germany
  • Jauch-Speer, Saskia-L., Universitatsklinikum Hamburg-Eppendorf, Hamburg, Hamburg, Germany
  • Sivayoganathan, Varshi, Universitatsklinikum Hamburg-Eppendorf, Hamburg, Hamburg, Germany
  • Paust, Hans-Joachim, Universitatsklinikum Hamburg-Eppendorf, Hamburg, Hamburg, Germany
  • Wiech, Thorsten, Universitatsklinikum Hamburg-Eppendorf, Hamburg, Hamburg, Germany
  • Huber, Tobias B., Universitatsklinikum Hamburg-Eppendorf, Hamburg, Hamburg, Germany
  • Panzer, Ulf, Universitatsklinikum Hamburg-Eppendorf, Hamburg, Hamburg, Germany
  • Bonn, Stefan, Universitatsklinikum Hamburg-Eppendorf, Hamburg, Hamburg, Germany
  • Krebs, Christian F., Universitatsklinikum Hamburg-Eppendorf, Hamburg, Hamburg, Germany
Background

Rapidly progressive glomerulonephritis (RPGN) represents the most aggressive form of autoimmune kidney disease and is characterized by the formation of glomerular crescents and the infiltration of immune cells. However, a detailed definition of leukocyte composition, cellular localization and the interactions of immune cells with renal tissue cells leading to the formation of glomerular crescents and loss of renal function is lacking.

Methods

We employed high-dimensional in situ mRNA detection (10x Xenium) to investigate immune cell infiltration and kidney cell reactions in patients with RPGN (ANCA-GN: n= 32; lupus nephritis: n=19; anti-GBM: n=6) and controls (n=6). Based on single-cell RNA-seq and spatial transcriptomics data from kidney samples from the same cohort, we designed a panel consisting of 480 probes for mRNA detection to cover a broad range of immune cells, parenchymal kidney cells and potential drivers of tissue inflammation. We used manual annotation as well as a graph neural network (GNN)-based clustering algorithm to define kidney niches.

Results

Our analysis resulted in a total of 2,899,179 cells from all disease categories and the panel enabled the definition and localization of all major immune and kidney cell types. Gene-expression-based pseudotime analysis from annotated glomeruli provided a trajectory from healthy glomeruli identified most frequently in control samples to severely damaged glomeruli mainly from anti-GBM patients. Patients with ANCA-GN showed glomeruli with all stages of the pseudotime. These analyses define the sequential recruitment of proinflammatory T cells and macrophages into inflammatory niches causing changes in cellular composition and crosstalk between different cell types and resulting in altered transcriptional profiles of epithelial kidney cells leading to crescent formation.

Conclusion

This integrated high-dimensional spatial immune and kidney cell atlas of healthy and RPGN kidneys represents a comprehensive benchmark of the cellular players with their localization and interactions in glomerular pathology. This is the basis for a better understanding of the cellular and molecular mechanisms required to develop targeted therapies in glomerulonephritis.

Funding

  • Government Support – Non-U.S.